Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Type 1 selected

Type

Guidance programme

Showing 1 to 21 of 21

TitleReference numberPublishedLast updated
Endoscopic duodenal mucosal resurfacing for insulin resistance in type 2 diabetesIPG787
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetesTA943
Tirzepatide for treating type 2 diabetesTA924
Diabetes (type 1 and type 2) in children and young people: diagnosis and managementNG18
Finerenone for treating chronic kidney disease in type 2 diabetesTA877
Type 1 diabetes in adults: diagnosis and managementNG17
Type 2 diabetes in adults: managementNG28
Diabetes in pregnancy: management from preconception to the postnatal periodNG3
Sotagliflozin with insulin for treating type 1 diabetesTA622
Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetesTA583
Ertugliflozin as monotherapy or with metformin for treating type 2 diabetesTA572
Type 2 diabetes: prevention in people at high riskPH38
Dapagliflozin in combination therapy for treating type 2 diabetesTA288
Dapagliflozin in triple therapy for treating type 2 diabetesTA418
Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetesTA390
Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetesIPG518
Empagliflozin in combination therapy for treating type 2 diabetesTA336
Canagliflozin in combination therapy for treating type 2 diabetesTA315
Type 2 diabetes prevention: population and community-level interventionsPH35
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitusTA151
Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitusIPG257

Results per page

  1. 10
  2. 25
  3. 50
  4. All